Funding · Company
Allay Therapeutics, Inc.
San Jose, CABiotech & Pharma
Allay Therapeutics, Inc. of San Jose, CA has disclosed $132M across 2 Form D offerings filed with the SEC between Dec 21, 2023 and Feb 10, 2025.
$132M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$45M
Form D · Feb 10, 2025 ↗
Q1 2025
· target $60M
$87M
Form D · Dec 21, 2023 ↗
Q4 2023
· 1 amendment, first filed Sep 20, 2021
Filing details
HeadquartersSan Jose, CAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001766366Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →